NO143224C - Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner - Google Patents

Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner

Info

Publication number
NO143224C
NO143224C NO752423A NO752423A NO143224C NO 143224 C NO143224 C NO 143224C NO 752423 A NO752423 A NO 752423A NO 752423 A NO752423 A NO 752423A NO 143224 C NO143224 C NO 143224C
Authority
NO
Norway
Prior art keywords
hydroxyalkylxanthines
procedure
preparation
Prior art date
Application number
NO752423A
Other languages
English (en)
Norwegian (no)
Other versions
NO752423L (de
NO143224B (no
Inventor
Alfons Soeder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO752423L publication Critical patent/NO752423L/no
Publication of NO143224B publication Critical patent/NO143224B/no
Publication of NO143224C publication Critical patent/NO143224C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO752423A 1974-07-05 1975-07-04 Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner NO143224C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (3)

Publication Number Publication Date
NO752423L NO752423L (de) 1976-01-06
NO143224B NO143224B (no) 1980-09-22
NO143224C true NO143224C (no) 1981-01-02

Family

ID=27048497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752423A NO143224C (no) 1974-07-05 1975-07-04 Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner

Country Status (14)

Country Link
JP (1) JPS5250800B2 (de)
AR (1) AR210330A1 (de)
AT (1) AT339917B (de)
CA (1) CA1062710A (de)
CH (2) CH622519A5 (de)
DK (1) DK140214B (de)
ES (1) ES439141A1 (de)
FI (1) FI59249C (de)
FR (1) FR2277089A1 (de)
GB (1) GB1500039A (de)
LU (1) LU72897A1 (de)
NL (1) NL166476C (de)
NO (1) NO143224C (de)
SE (2) SE420097B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
NL7507976A (nl) 1976-01-07
CA1062710A (en) 1979-09-18
ES439141A1 (es) 1977-02-16
FI59249C (fi) 1981-07-10
FI59249B (fi) 1981-03-31
SE427183B (sv) 1983-03-14
CH622018A5 (en) 1981-03-13
JPS5250800B2 (de) 1977-12-27
GB1500039A (en) 1978-02-08
NO752423L (de) 1976-01-06
FR2277089A1 (fr) 1976-01-30
DK140214C (de) 1979-12-03
SE420097B (sv) 1981-09-14
NO143224B (no) 1980-09-22
AU8275575A (en) 1977-01-06
FI751958A (de) 1976-01-06
ATA517275A (de) 1977-03-15
CH622519A5 (en) 1981-04-15
NL166476B (nl) 1981-03-16
SE7507726L (sv) 1976-01-06
LU72897A1 (de) 1976-05-31
JPS5134194A (de) 1976-03-23
AR210330A1 (es) 1977-07-29
DK140214B (da) 1979-07-09
AT339917B (de) 1977-11-10
SE7807853L (sv) 1978-07-14
FR2277089B1 (de) 1978-03-17
DK301775A (de) 1976-01-06
NL166476C (nl) 1981-08-17

Similar Documents

Publication Publication Date Title
NO148712C (no) Fremgangsmaate ved fremstilling av etylidendiacetat
NO143940C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere
NO147037C (no) Fremgangsmaate ved fremstilling av cellulosemasse
NO145075C (no) Kontinuerlig fremgangsmaate til fremstilling av alkoksysilaner
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7513085L (sv) Forfarande for framstellning av etrar
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE426828B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner eller 6beta-acylamino-6alfa-alkoxipenicilliner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
NO144111C (no) Fremgangsmaate ved fremstilling av immunoglobulinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO791267L (no) Fremgangsmaate ved fremstilling av 5-fluor-2-methyl-indanol-3-eddiksyreforbindelser
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
NO147671C (no) Fremgangsmaate ved fremstilling av 2-deutero-3-fluor-dl-alanin
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
NO143478C (no) Fremgangsmaate ved fremstilling av gamma-globuliner
SE427925B (sv) Forfarande for framstellning av o-hydroxibensylalkoholer
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat